News

13 Jan 2020

4Dx Hiring

4Dx is continuing to grow! Two new job postings for the Melbourne office were posted today on our Careers page: https://4dx.com/careers

READ POST
10 Dec 2019

4Dx $15 million Pre-IPO News Hits News Outlets

New news releases from BioMelbourne Network and Biotech Daily, Dec. 10, 2019: (https://biotechdispatch.com.au/news/4dx-raises-15m-in-oversubscribed-capital-raise)   ****************** 10 December 2019 Melbourne, Australia: Australian medical technology company 4Dx Limited has raised $15 million in a heavily oversubscribed pre-IPO. The funds raised via the unsecured converting note issue will be used to drive 4Dx’s go-to-market strategy by adding to […]

READ POST
15 Nov 2019

4Dx Completes FDA Submission Documentation

FOR IMMEDIATE RELEASE As of November 10, 2019, 4Dx is proud to announce that all documents required to support an FDA 510(k) application have been handed over to its agent for electronic submission. After a tremendously successful clinical validation trial, 4Dx founder and CEO, Andreas Fouras, was very happy to announce the trial’s results, which […]

READ POST
12 Nov 2019

Dr. Sam Hupert, CEO of Pro Medicus, Joins 4Dx Advisory Board

4Dx is pleased to announce the appointment of Dr. Sam Hupert, co-Founder and CEO of Pro Medicus (ASX: PME) to the 4Dx advisory board. Dr. Hupert has made a private investment into 4Dx and agreed to sit on 4Dx’s advisory board, bringing with him more than 37 years of success as a leader in the global […]

READ POST
05 Nov 2019

Biotech Daily – “4DX: ‘XV BEATS PFT, CT FOR LUNG HEALTH’”

From Biotech Daily – released Friday, November 1, 2019   4DX LIMITED 4DX says a 32-patient, 13-month study shows that its XV technology is superior to “gold standard pulmonary diagnostics” to measure lung health. 4DX said the study, titled ‘Novel x-ray velocimetry based quantitative regional lung function analysis to assess risk of radiation-induced pneumonitis and […]

READ POST
31 Oct 2019

New 4Dx article on Stockhead website

A new article was posted today on Stockhead.com, an online health & technology news service focusing on big discoveries, medical breakthroughs and revolutionary technologies. Check it out! 4Dx’s lung imaging technology just passed a clinical trial. Next step — an ASX listing

READ POST
19 May 2019

4Dx Presents First Human Scan Data From XV Technology Clinical Trials

Andreas Fouras, PhD, (founder and CEO of 4Dx) presented this week the first release of the highly anticipated results from 4Dx’s clinical trials at the American Thoracic Society (ATS) 2019 International Conference in Dallas, TX, 4Dx opened Day 1 of the 3-day conference with a newly-designed booth dedicated to showcasing the first of many 4-dimensional […]

READ POST
26 Apr 2019

FUNDING FOR GROUND-BREAKING LUNG DIAGNOSTIC TECHNOLOGY

 The Hon. Greg Hunt MP  Minister for Health  MEDIA RELEASE  FUNDING FOR GROUND-BREAKING LUNG DIAGNOSTIC TECHNOLOGY  The Liberal National Government will provide $960,000 for intensive research into new 4D diagnostic technology to allow accurate assessment of lung function in patients of all ages including the very sick.  The Australian Lung Health Initiative headed by Professor […]

READ POST